S. Jamil, G. Jamil, H. Mesameh et al. Risk factor comparison in young patients presenting with acute coronary syndrome with atherosclerotic coronary artery disease vs. angiographically normal coronaries. Int. J. Med. Sci. 1815, 3526–3532 (2021)
M.K. Jensen, S.E. Chiuve, E.B. Rimm et al. Obesity, behavioral lifestyle factors, and risk of acute coronary events. Circulation 11724, 3062–3069 (2008)
M.C. Madala, B.A. Franklin, A.Y. Chen et al. Obesity and age of first non-ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 5212, 979–985 (2008)
Z. Wang, X. Hui, X. Huang et al. Relationship between a novel non-insulin-based metabolic score for insulin resistance (METS-IR) and coronary artery calcification. BMC Endocr. Disord. 221, 274 (2022)
C.J. Lavie, D. Laddu, R. Arena et al. Healthy Weight and obesity prevention: JACC health promotion series. J. Am. Coll. Cardiol. 7213, 1506–1531 (2018)
M.B. Schulze, Metabolic health in normal-weight and obese individuals. Diabetologia 624, 558–566 (2019)
M. Blüher, The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr. Opin. Lipidol. 211, 38–43 (2010)
C. Lassale, I. Tzoulaki, K.G.M. Moons et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur. Heart J. 395, 397–406 (2018)
X. Feng, Y. Liu, J. Yang et al. The combined predictive power of the atherogenic index of plasma and serum glycated albumin for cardiovascular events in postmenopausal patients with acute coronary syndrome after percutaneous coronary intervention. Lipids Health Dis. 231, 352 (2024)
Q. Guo, X. Feng, B. Zhang et al. Influence of the triglyceride-glucose index on adverse cardiovascular and cerebrovascular events in prediabetic patients with acute coronary syndrome. Front. Endocrinol. 13, 843072 (2022)
X. Feng, Y. Liu, J. Yang et al. Evaluation of estimated glucose disposal rate with neutrophil-to-lymphocyte ratio integrated for prognosticating adverse cardiovascular and cerebrovascular events and risk stratification among acute coronary syndrome with type 2 diabetes mellitus following percutaneous coronary intervention. J. Inflamm. Res. 17, 9193–9214 (2024)
Article PubMed PubMed Central Google Scholar
A.A. Kammerlander, T. Mayrhofer, M. Ferencik et al. Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain. Diabetes Care 444, 1038–1045 (2021)
M. Kivimäki, E. Kuosma, J.E. Ferrie et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public. Health 26, e277–e285 (2017)
P. Costanzo, J.G. Cleland, P. Pellicori et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann. Intern. Med. 1629, 610–618 (2015)
D. Demirci, D.E. Demirci, G. Chi, Association between obesity grade and the age of the first acute coronary syndrome: Prospective observational study. Int. J. Cardiol. 351, 93–99 (2022)
J.V. van Vliet-Ostaptchouk, M.L. Nuotio, S.N. Slagter et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr. Disord. 14, 9 (2014)
Article PubMed PubMed Central Google Scholar
E. Lopez-Garcia, P. Guallar-Castillon, L. Leon-Muñoz et al. Prevalence and determinants of metabolically healthy obesity in Spain. Atherosclerosis 2311, 152–157 (2013)
T. Mahendiran, A. Hoepli, F. Foster-Witassek et al. 20-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalised in Switzerland. Eur. J. Prev. Cardiol. 30, 1504–1512 (2023)
A.W. Tutor, C.J. Lavie, S. Kachur et al. Updates on obesity and the obesity paradox in cardiovascular diseases. Prog. Cardiovasc. Dis. 78, 2–10 (2023)
R. Caleyachetty, G.N. Thomas, K.A. Toulis et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J. Am. Coll. Cardiol. 7012, 1429–1437 (2017)
D.P. Guh, W. Zhang, N. Bansback et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public. Health 9, 88 (2009)
Article PubMed PubMed Central Google Scholar
Q. Li, P. Wang, R. Ma et al. A novel criterion of metabolically healthy obesity could effectively identify individuals with low cardiovascular risk among Chinese cohort. Front. Endocrinol. 14, 1140472 (2023)
Y. Xu, H. Li, A. Wang et al. Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study. Eur. J. Endocrinol. 1796, 343–352 (2018)
J. Niedziela, B. Hudzik, N. Niedziela et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur. J. Epidemiol. 2911, 801–812 (2014)
C.H. Sia, J. Ko, H. Zheng et al. Association of body mass index, metabolic health status and clinical outcomes in acute myocardial infarction patients: a national registry-based study. Front. Cardiovasc. Med. 10, 1142078 (2023)
Article PubMed PubMed Central Google Scholar
F.B. Ortega, D.C. Lee, P.T. Katzmarzyk et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur. Heart J. 345, 389–397 (2013)
N.W.S. Chew, G. Kong, S. Venisha et al. Long-term prognosis of acute myocardial infarction associated with Metabolic Health and Obesity Status. Endocr. Pract. 288, 802–810 (2022)
G.M. Hinnouho, S. Czernichow, A. Dugravot et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur. Heart J. 369, 551–559 (2015)
Z.J. Wang, F. Gao, W.J. Cheng et al. Body mass index and repeat revascularization after percutaneous coronary intervention: a meta-analysis. Can. J. Cardiol. 316, 800–808 (2015)
Z. Balayah, A.A. Alsheikh-Ali, W. Rashed et al. Association of obesity indices with in-hospital and 1-year mortality following acute coronary syndrome. Int. J. Obes. 452, 358–368 (2021)
K. Kondo, R. Shibata, K. Unno et al. Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model. Circ. Cardiovasc. Interv. 32, 166–173 (2010)
L. Tao, E. Gao, X. Jiao et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 11511, 1408–1416 (2007)
O. Angerås, P. Albertsson, K. Karason et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish coronary angiography and angioplasty registry. Eur. Heart J. 345, 345–353 (2013)
V. Primeau, L. Coderre, A.D. Karelis et al. Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. 357, 971–981 (2011)
J. Naukkarinen, S. Heinonen, A. Hakkarainen et al. Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia 571, 167–176 (2014)
A.D. Ogorodnikova, M. Kim, A.P. McGinn et al. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity 203, 651–659 (2012)
M. Blüher, Metabolically healthy obesity. Endocr. Rev. 41, bnaa004 (2020)
Article PubMed PubMed Central Google Scholar
Stefan, N. Häring HU, F.B. Hu et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 12, 152–162 (2013)
G. Aisike, M. Kuerbanjiang, D. Muheyati et al. Correlation analysis of obesity phenotypes with leptin and adiponectin. Sci. Rep. 131, 17718 (2023)
A. Barseghian, D. Gawande, M. Bajaj, Adiponectin and vulnerable atherosclerotic plaques. J. Am. Coll. Cardiol. 577, 761–770 (2011)
Comments (0)